109 related articles for article (PubMed ID: 2342075)
41. Platinum complexes with imino ethers or cyclic ligands mimicking imino ethers: synthesis, in vitro antitumour activity, and DNA interaction properties.
Intini FP; Boccarelli A; Francia VC; Pacifico C; Sivo MF; Natile G; Giordano D; De Rinaldis P; Coluccia M
J Biol Inorg Chem; 2004 Sep; 9(6):768-80. PubMed ID: 15241660
[TBL] [Abstract][Full Text] [Related]
42. Synthesis and antineoplastic properties of an ether glycerophosphonocholine, and analog of ET-18-OCH3-GPC.
Salari H; Howard S; Bittman R
Biochem Biophys Res Commun; 1992 Sep; 187(2):603-8. PubMed ID: 1530618
[TBL] [Abstract][Full Text] [Related]
43. Differential effect of alkyl chain-modified ether lipids on protein kinase C autophosphorylation and histone phosphorylation.
Gil C; Molina E; Plana M; Carabaza A; Cabré F; Mauleón D; Carganico G; Itarte E
Biochem Pharmacol; 1996 Dec; 52(12):1843-7. PubMed ID: 8951342
[TBL] [Abstract][Full Text] [Related]
44. Syntheses of racemic and nearly optically pure ether lipids and evaluation of in vitro antineoplastic activities.
Duclos RI; Chia HH; Abdelmageed OH; Esber H; Fournier DJ; Makriyannis A
J Med Chem; 1994 Nov; 37(24):4147-54. PubMed ID: 7990114
[TBL] [Abstract][Full Text] [Related]
45. Differentiation of HL-60 cells distinguishes between cytostatic and cytotoxic effects of the alkylphospholipid ET-18-OCH3.
Civoli F; Pauig SB; Daniel LW
Cancer Chemother Pharmacol; 1996; 38(3):269-72. PubMed ID: 8646802
[TBL] [Abstract][Full Text] [Related]
46. Effects of antineoplastic ether lipids on model and biological membranes.
Noseda A; Godwin PL; Modest EJ
Biochim Biophys Acta; 1988 Nov; 945(1):92-100. PubMed ID: 3179313
[TBL] [Abstract][Full Text] [Related]
47. Synthesis of Bioconjugate Sesterterpenoids with Phospholipids and Polyunsaturated Fatty Acids.
Gil-Mesón A; Roncero AM; Tobal IE; Basabe P; Díez D; Mollinedo F; Marcos IS
Molecules; 2015 Dec; 21(1):E47. PubMed ID: 26729084
[TBL] [Abstract][Full Text] [Related]
48. Synthesis, antiinflammatory and anticancer activity of cinnamic acids, their derivatives and analogues.
Zhang LP; Ji ZZ
Yao Xue Xue Bao; 1992; 27(11):817-23. PubMed ID: 1300025
[TBL] [Abstract][Full Text] [Related]
49. In vitro antiproliferative activity of combinations of ether lipid analogues and DNA-interactive agents against human tumor cells.
Noseda A; Berens ME; White JG; Modest EJ
Cancer Res; 1988 Apr; 48(7):1788-91. PubMed ID: 3349458
[TBL] [Abstract][Full Text] [Related]
50. Synthesis and antineoplastic properties of ether-linked thioglycolipids.
Guivisdalsky PN; Bittman R; Smith Z; Blank ML; Snyder F; Howard S; Salari H
J Med Chem; 1990 Sep; 33(9):2614-21. PubMed ID: 2391700
[TBL] [Abstract][Full Text] [Related]
51. Correlation between the effect of the anti-neoplastic ether lipid 1-O-octadecyl-2-O-methyl-glycero-3-phosphocholine on the membrane and the activity of protein kinase Calpha.
Aroca JD; Sánchez-Piñera P; Corbalán-García S; Conesa-Zamora P; de Godos A; Gómez-Fernández JC
Eur J Biochem; 2001 Dec; 268(24):6369-78. PubMed ID: 11737191
[TBL] [Abstract][Full Text] [Related]
52. Protein kinase C is not involved in the cytotoxic action of 1-octadecyl-2-O-methyl-sn-glycerol-3-phosphocholine in HL-60 and K562 cells.
Heesbeen EC; Verdonck LF; Staal GE; Rijksen G
Biochem Pharmacol; 1994 Apr; 47(9):1481-8. PubMed ID: 8185658
[TBL] [Abstract][Full Text] [Related]
53. Selective inhibition of phosphatidylinositol phospholipase C by cytotoxic ether lipid analogues.
Powis G; Seewald MJ; Gratas C; Melder D; Riebow J; Modest EJ
Cancer Res; 1992 May; 52(10):2835-40. PubMed ID: 1316230
[TBL] [Abstract][Full Text] [Related]
54. Enzymatic release of antitumor ether lipids by specific phospholipase A2 activation of liposome-forming prodrugs.
Andresen TL; Davidsen J; Begtrup M; Mouritsen OG; Jørgensen K
J Med Chem; 2004 Mar; 47(7):1694-703. PubMed ID: 15027860
[TBL] [Abstract][Full Text] [Related]
55. Multiparametric flow cytometry of the modulation of tumor cell membrane permeability by developmental antitumor ether lipid SRI 62-834 in EMT6 mouse mammary tumor and HL-60 human promyelocytic leukemia cells.
Dive C; Watson JV; Workman P
Cancer Res; 1991 Feb; 51(3):799-806. PubMed ID: 1988120
[TBL] [Abstract][Full Text] [Related]
56. In vitro gene transfer efficacies of N,N-dialkylpyrrolidinium chlorides: a structure-activity investigation.
Majeti BK; Karmali PP; Reddy BS; Chaudhuri A
J Med Chem; 2005 Jun; 48(11):3784-95. PubMed ID: 15916430
[TBL] [Abstract][Full Text] [Related]
57. New synthetic aliphatic sulfonamido-quaternary ammonium salts as anticancer chemotherapeutic agents.
Song D; Yang JS; Oh C; Cui S; Kim BK; Won M; Lee JI; Kim HM; Han G
Eur J Med Chem; 2013 Nov; 69():670-7. PubMed ID: 24095759
[TBL] [Abstract][Full Text] [Related]
58. Farnesylpyridinium, an analog of isoprenoid farnesol, induces apoptosis but suppresses apoptotic body formation in human promyelocytic leukemia cells.
Hamada M; Nishio K; Doe M; Usuki Y; Tanaka T
FEBS Lett; 2002 Mar; 514(2-3):250-4. PubMed ID: 11943160
[TBL] [Abstract][Full Text] [Related]
59. [Comparison of the sensitivity of retinoic acid sensitive and resistant HL-60 cell lines to several anti-leukemia drugs].
Li L; Xia L; Han R
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1994 Dec; 16(6):469-72. PubMed ID: 7720148
[TBL] [Abstract][Full Text] [Related]
60. A comparative study of the effect of the antineoplastic ether lipid 1-O-octadecyl-2-O-methyl-glycero-3-phosphocholine and some homologous compounds on PKC alpha and PKC epsilon.
Conesa-Zamora P; Mollinedo F; Corbalán-García S; Gómez-Fernández JC
Biochim Biophys Acta; 2005 Feb; 1687(1-3):110-9. PubMed ID: 15708359
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
